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Abstract
In the present study, we first report an in vivo characterization of flexor responses induced by three
distinct sine-wave stimuli in the electrical stimulation-induced paw flexion (EPF) test in mice. The
fixed sine-wave electric stimulations of 5 Hz (C-fiber), 250 Hz (Aδ-fiber) and 2000 Hz (Aβ-fiber)
to the hind paw of mice induced a paw-flexion response and vocalization. The average threshold
for paw flexor responses by sine-wave stimulations was much lower than that for vocalization.
Neonatally (P3) pretreatment with capsaicin to degenerate polymodal substance P-ergic C-fiber
neurons increased the threshold to 5 Hz (C-fiber) stimuli, but not to 250 Hz (Aδ-fiber) and 2000
Hz (Aβ-fiber). The flexor responses to 5 Hz stimuli were significantly blocked by intrathecal (i.t.)
pretreatment with both CP-99994 and MK-801, an NK1 and NMDA receptor antagonist,
respectively, but not by CNQX, an AMPA/kainate receptor antagonist. On the other hand, the
flexor responses induced by 250 Hz stimuli were blocked by MK-801 (i.t.) but not by CP-99994 or
CNQX. In contrast, flexor responses induced by 2000 Hz stimuli were only blocked by CNQX
treatment. These data suggest that we have identified three pharmacologically different categories
of responses mediated through different primary afferent fibers. Furthermore, we also carried out
characterization of the in vivo functional sensitivity of each of the sensory fiber types in nerve-
injured mice using the EPF test, and found that the threshold to both 250 Hz and 2000 Hz
stimulations were markedly decreased, whereas the threshold to 5 Hz stimulations was significantly
increased. Thus we found opposing effects on specific sensory fiber-mediated responses as a result
of nerve injury in mice. These results also suggest that the EPF analysis is useful for the evaluation
of plasticity in sensory functions in animal disease models.
Findings
Primary afferent fibers have been classified into three
major types, C-, Aδ-, and Aβ-fibers. To unveil the specific
role of each of these fiber types in pain sensation, many in
vivo models have been developed. In many cases, the ani-
mals' response to various painful stimuli, consisting of
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thermal, mechanical or chemical challenges, is measured
as the output parameter, and each of these types of stimuli
have proven to partly mimic clinical symptoms observed
in patients and healthy subjects [1,2]. However, the mech-
anisms that lead from stimuli to response are unclear but
is expected to consist of both direct and indirect actions
[3,4], and a better understanding may lead to novel treat-
ment strategies.
We recently developed a technique that measures the
paw-flexion-response induced by extremely low doses of
algogenics (algogenic-induced paw flexion or APF test)
[5]. Combined with neonatal capsaicin-induced C-fiber
elimination and spinal receptor antagonism, we catego-
rized nociception into three types. Type 1 is induced by
bradykinin, SP or histamine, while type 2 is induced by
ATP. Furthermore, type 1 and 2 nociception are mediated
through SP-NK1 and glutamate-NMDA receptor spinal
transmission, respectively. However, they both are capsa-
icin-sensitive fibers [5]. This classification is similar to the
schematic model proposed by Snider and McMahon [6].
In contrast to type 1 and 2 nociception, type 3 nociception
induced by prostaglandin I2 receptor agonists is mediated
by capsaicin-insensitive fibers and spinal transmission
through glutamate-NMDA receptors, possibly reflecting
Aδ-fiber signaling [5]. The physiological function of Aβ-
fibers is thought to be conduction of innocuous tactile
input, though they may possess nociceptive properties [7].
To evaluate the sensory transduction, especially concern-
ing that of Aβ-fibers, we utilized the Neurometer®, an
apparatus that selectively activates sensory neurons by use
of sine-wave pulses of different frequencies. In humans,
frequencies of 5, 250 and 2000 Hz activates C-, Aδ- and
Aβ-fibers respectively. This test is widely used clinically to
evaluate sensory function in patients suffering from
peripheral neuropathic pain [8-11]. However, as the char-
acterization of these stimuli-induced responses in animals
remains to be clarified, we examined the flexor responses
induced by the three distinct stimuli (5, 250 and 2000 Hz)
in the EPF test, which is derived from the APF test [5,12].
Next, we also determined the functional responses in each
nociceptor type in a murine nerve-injury model.
Male ddY mice weighing 20–22 g, were adapted to labora-
tory condition; 22 ± 2°C, 55 ± 5 % relative humidity and
a 12-hour light/dark cycle with food and water ad libitum.
All procedures were approved by Nagasaki University Ani-
mal Care Committee and complied with the recommen-
dations of IASP [13]. The following drugs were used:
capsaicin (Nacalai Tesque, Kyoto, Japan), MK-801
(Research Biochemical, USA) and CNQX (Sigma, USA).
CP-99994 and capsaicin cream were generously provided
by Pfizer Pharmaceuticals (Sandwich, Kent, UK) and
Maruishi Pharmaceutical Co. (Osaka, Japan), respectively.
All drugs except capsaicin were dissolved in physiological
saline. Neonatal capsaicin or capsaicin cream treatments
were carried out as previously reported [14-16]. Partial sci-
atic nerve ligation was performed under pentobarbital (50
mg/kg, i.p.) anesthesia, as described previously [16,17].
Tests were carried out 7 days after nerve ligation.
While tested, mice were suspended from a metal bar in a
cloth sling, with their 4 limbs hanging free through holes.
All limbs were tied with strings; 3 were fixed to the bench,
while the 4th was connected to an isotonic transducer and
recorder. Electrodes were attached to the right hind paw
plantar surface and instep (Fig. 1A) and fastened with
tape. Twenty minutes after attaching the electrodes the
mice were calm and the chart was steady. Then, nerve
stimuli with each of the three pulses (5, 250 and 2000 Hz)
were applied using the "manual mode" of the Neurometer
(Neurotron Inc., Baltimore, MD). The basal level of the
chart line was the same from beginning to end in experi-
ments. In this experiment, stimuli were applied with 5
min intervals. The minimum intensity (in µA) to induce a
flexor response (EPF) or vocalization [18] was defined as
the stimulus threshold.
Fig. 1B demonstrates the representative traces of flexor
responses by 5, 250 and 2000 Hz stimulations. The aver-
ages thresholds to induce flexor responses by such stimu-
lations were 26.0, 147.5 and 440.7 µA, respectively (Table
1). Repeated stimulations by 250 Hz induced consistent
flexor responses (Fig. 1B), and so did the stimulation by 5
or 2000 Hz (data not shown). The thresholds for vocaliza-
tion responses to 5, 250 and 2000 Hz stimulation were
much higher than those for the flexor response (Fig. 1C).
Table 1: Capsaicin sensitivity. Neonatal capsaicin treatment and capsaicin cream reduced sensitivity measured as flexor responses to 
electrical stimulations with three different frequencies. *:p < 0.05. Data (µA) are presented as means ± S.E.M. from experiments using 
at least 6 mice.
Veh-mice Cap-mice Basement Cap cream
5 Hz 26.0 ± 2.6 95.8 ± 22.7 * 29.3 ± 4.6 74.5 ± 2.3 *
250 Hz 147.5 ± 17.8 155.4 ± 33.0 143.9 ± 34.4 158.0 ± 15.3
2000 Hz 440.7 ± 16.1 414.0 ± 18.9 423.7 ± 41.9 476.0 ± 43.7Molecular Pain 2006, 2:16 http://www.molecularpain.com/content/2/1/16
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Table 1 demonstrates the capsaicin-sensitivity. Only the
threshold for 5 Hz stimulations was significantly
increased by neonatal-capsaicin and capsaicin cream
treatments, which degenerate and desensitize C-fibers,
respectively [14,15], while those for 250 Hz and 2000 Hz
were not. The characterization of spinal pain transmission
is shown in Fig. 1D–1F. The treatment 20 min prior to EPF
tests with CP-99994 or MK-801 (3 nmol, i.t.), an NK1 and
NMDA receptor antagonist, respectively, significantly
increased the threshold of the 5 Hz response while no
effect was observed with CNQX (3 nmol, i.t.), an AMPA/
kainate receptor antagonist (Fig. 1D). However, the 250
Hz threshold was increased by MK-801 but not by CP-
99994 or CNQX pretreatment (Fig. 1E). Finally we found
that the 2000 Hz threshold was increased by CNQX but
not by CP-99994 or MK-801 pretreatment (Fig. 1F).
Next, we evaluated the functional responses of each of the
primary sensory fibers in the partial sciatic nerve ligation
model of neuropathic pain. The 5 Hz threshold was signif-
icantly increased on day seven after operation (Fig. 1G),
Spinal transmission in flexor responses induced by three different sine-wave electrical stimuli Figure 1
Spinal transmission in flexor responses induced by three different sine-wave electrical stimuli. (A) Attachment of 
electrodes to the right hind paw plantar surface and instep of the mice. Arrowheads indicate electrode. (B) Representative 
trace of each of three different sine-wave (5, 250 and 2000 Hz) stimulus-induced responses. The intensity of each stimulus was 
gradually increased. (C) Average electrical stimulation thresholds for vocalization and paw flexor responses. (D-F) Sensitivity of 
NK1, NMDA and AMPA/kainate antagonists on three different sine-wave (5, 250 and 2000 Hz) stimulus-induced responses in 
the EPF test. (G-I) Opposite effects on C- and A-fiber-mediated response by nerve injury in mice. Sensitivity was determined 
by EPF tests on day 7 after sciatic nerve injury. The data were analyzed using Student's t-test. Significance was set to *p < 0.05. 
Data in these figures are presented as means S.E.M. from experiments using at least 6 mice.Molecular Pain 2006, 2:16 http://www.molecularpain.com/content/2/1/16
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while the 250 Hz and 2000 Hz thresholds were signifi-
cantly decreased (Fig. 1H and 1I).
The present study demonstrates that the 5 Hz or C-fiber
responses are mediated through capsaicin-sensitive fibers
and SP-NK1 receptor as well as glutamate-NMDA receptor
spinal transmission. These findings are in a good accord-
ance with our previous studies using the APF test, in which
C-fiber-mediated nociceptive responses are sensitive to
the NK1 antagonist (CP-99994) or the NMDA receptor
antagonist (MK-801) [5]. The 250 Hz-responses are medi-
ated through capsaicin-insensitive fibers and glutamate-
NMDA-receptor spinal transmission. As type 3 nocicep-
tion is mediated by capsaicin-insensitive fibers and gluta-
mate-NMDA-receptor spinal transmission [5], the 250 Hz
stimuli may activate at least type 3 fibers. Furthermore, we
found that the 2000 Hz response is mediated through
capsaicin-insensitive fibers as well, but depends on gluta-
mate-AMPA/kainate-receptor transmission.
It seems to be unique that MK-801, but not CNQX inhib-
ited the nociceptive responses by Aδ (250 Hz) stimula-
tion, since NMDA receptor activation is known to require
depolarization through AMPA receptors for removing the
Mg2+ block. Regarding the lack of contribution of AMPA
receptors to the NMDA receptor-mediated nociceptions,
there are some other possibilities for selective NMDA
receptor activation. In the presence of ephrinB2-EphB2
activation, glutamate-induced excitatory postsynaptic
potential (EPSP) was blocked by MK-801, but not by
CNQX [19]. In fura-2 imaging experiments, it was
revealed that the [Ca2+]i increase in spinal lamina I neu-
rons by electrical stimulations was blocked by D-AP5, an
NMDA receptor antagonist, but not by CNQX [20]. From
the fact that the single-channel conductance and open
channel probability of NMDA receptor-mediated currents
(~30 pS, ~10 msec) are longer than AMPA/kainate recep-
tor-mediated one (2–10 pS, 2–5 msec), the NMDA recep-
tor currents seem to be more liable to be cumulated to
generate action potentials than AMPA receptor ones
under the condition of repetitive stimulation by Neurom-
eter, as shown in the present study.
The present findings firstly demonstrate that the spinal
pain transmission through Aδ- or Aβ-fibers is differen-
tially mediated through glutamate-NMDA receptors or
glutamate-AMPA receptors, respectively. Such a distinct
characterization would be attributed to the fact that we
used low-intensity stimulation of 2000 Hz, since higher
intensity stimulations (>2,200 µA) activates Aδ-fibers as
well as Aβ-fibers, as seen in the recent electrophysiological
study using Neurometer [21].
We also demonstrate that opposite changes in the sensi-
tivity of C-fiber- and A-fiber-mediated responses were
induced in mice after pretreated with partial sciatic nerve
injury. These findings are consistent with our previous
studies using APF test, in which type 1 nociceptive
responses through C-fibers were lost, while type 3 nocice-
ptive responses (possibly through Aδ-fibers) were
enhanced by nerve injury [5,16]. The present findings pro-
vide further the evidence that nociceptive responses
through Aβ-fibers are also enhanced. Although the under-
lying mechanisms remain to be clarified, reduced C-fiber
responses are likely related to the decrease in dorsal horn
SP-immunoreactivity in neuropathic pain models [17],
while enhanced A-fiber responses are related to the up-
regulation of calcium and sodium channels as well as to
demyelination [22,23]. In conclusion, this is the first
report of a murine in vivo characterization of the distinct
responses by C-, Aδ- and Aβ-fiber stimuli using Neurome-
ter. We found opposite effect on C- and A-fiber-mediated
responses following partial sciatic nerve injury, suggesting
that targeting A-fibers, responsible for neuropathic pain
but not C-fibers, is a potential clinical treatment strategy.
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